S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

Taipei Medical University

Status and phase: Unknown; Phase 4

Conditions: Liver Diseases

Treatments: Drug: Shen Pu Yang Gan Wan; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT04718051

N202007032

Details and patient eligibility

About

With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.

Full description

With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy. Moreover, drugs also have side effects, and there is currently no convenient and effective treatment for people who have non-alcoholic fatty liver disease. The purpose of this trial is that investigating and evaluating the effects on fatty liver, liver fiber, and metabolic indexes after subjects using Shen Pu Yang Gan Wan.

Enrollment: 60 estimated patients

Sex: All

Ages: 35 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with fatty liver diagnosed by abdominal ultrasound or hepatic fibrometer within half a year's data
• Subjects with the non-alcoholic fatty liver disease
• The severity of fatty liver should be at least 3 points by taking an abdominal ultrasound

Exclusion criteria

• Female patients are pregnant or breastfeeding.
• Patients with viral hepatitis.
• Long-term drinkers.
• Those who use slimming products and vitamin E.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups, including a placebo group

Shen Pu Yang Gan Wan

Experimental group

Description:

Traditional Chinese Medicine

Treatment:

Drug: Shen Pu Yang Gan Wan

Placebo Comparator

Placebo Comparator group

Description:

Placebo Comparator

Treatment:

Drug: Placebo